Rabeprazole and Omeprazole in Peptic ulcer Treatment
Pan Run-hong
Abstract
Pan Run-hong
Abstract
Objective To study and compare rabeprazole and omeprazole in the treatment of peptic ulcer clinical efficacy.Methods Our hospital from February 2011 to March 2012,38 cases of peptic ulcer patients were randomly divided into 19 cases of rabeprazole group and omeprazole group.Rabeprazole group therapy with rabeprazole group,omeprazole,omeprazole treatment,the therapeutic effect of the two groups were compared.Results 89.5% of the rabeprazole group was much higher than 57.9% of the omeprazole group,said Mingleibeila azole significantly better than omeprazole,the difference was statistically significant(P0.05);rabeprazole group occurred only five patients,the types of adverse drug reactions,accounting for 26.32%.Omeprazole 11 patients,adverse drug reactions,accounting for 57.89%,the rabeprazole group incidence of adverse events was significantly lower than the omeprazole group,the difference was statistically significant(P0.05).Conclusion Rabeprazole treatment of peptic ulcer,rapid onset of action,and the role of durable,safe and reliable.Efficacy and adverse events are significantly superior to omeprazole,worthy of promotion and application
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study and compare rabeprazole and omeprazole in the treatment of peptic ulcer clinical efficacy.Methods Our hospital from February 2011 to March 2012,38 cases of peptic ulcer patients were randomly divided into 19 cases of rabeprazole group and omeprazole group.Rabeprazole group therapy with rabeprazole group,omeprazole,omeprazole treatment,the therapeutic effect of the two groups were compared.Results 89.5% of the rabeprazole group was much higher than 57.9% of the omeprazole group,said Mingleibeila azole significantly better than omeprazole,the difference was statistically significant(P0.05);rabeprazole group occurred only five patients,the types of adverse drug reactions,accounting for 26.32%.Omeprazole 11 patients,adverse drug reactions,accounting for 57.89%,the rabeprazole group incidence of adverse events was significantly lower than the omeprazole group,the difference was statistically significant(P0.05).Conclusion Rabeprazole treatment of peptic ulcer,rapid onset of action,and the role of durable,safe and reliable.Efficacy and adverse events are significantly superior to omeprazole,worthy of promotion and application
Key concepts: Rabeprazole, Omeprazole, Medicine, Gastroenterology, Peptic, Internal medicine, Adverse effect, Peptic ulcer